previous compound ID: 2159 next compound
InChIKey: SYCBXBCPLUFJID-UHFFFAOYSA-N
SMILES: CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "E Matthes" "D Rotin" "JW Hanrahan" "GW Carlile" "J Goepp" "B Kus" "SD Macknight" "J Liao" "R Robert"

chemical graph of compound 2159





CID is 73957
synonyms found at PubChem are:
Pramoxine hydrochloride, 637-58-1, Pramoxine HCl, Pramocaine hydrochloride, Prax Lotion, Tronolane, Tronothane hydrochloride, Pramocaine (hydrochloride), ProctoFoam-NS, UNII-88AYB867L5, HSDB 7220, EINECS 211-293-1, NSC 25573, Pramoxine hydrochloride [USP], MLS000028604, Morpholine, 4-[3-(4-butoxyphenoxy)propyl]-, hydrochloride, 88AYB867L5, 4-(3-(p-Butoxyphenoxy)propyl)morpholine hydrochloride, p-Butoxyphenyl gamma-morpholinopropyl ether hydrochloride, gamma-Morpholinopropyl 4-n-butoxyphenyl ether hydrochloride, Morpholine, 4-(3-(4-butoxyphenoxy)propyl)-, hydrochloride, SMR000058670, DSSTox_CID_27757, DSSTox_RID_82534, DSSTox_GSID_47777, Pramoxine hydrochloride (USP), Q-100732, 4-[3-(4-butoxyphenoxy)propyl]morpholine hydrochloride, p-Butoxyphenyl gamma-mopholinopropyl ether hydrochloride, Morpholine, 4-(3-(p-butoxyphenoxy)propyl)-, hydrochloride, NCGC00016529-01, CAS-637-58-1, 4-(3-(4-butoxyphenoxy)propyl)morpholine hydrochloride, 4-[3-(4-butoxyphenoxy)propyl]morpholine;hydrochloride, 4-[3-(p-Butoxyphenoxy)propyl]morpholine hydrochloride, SR-01000000243, Pramoxine, HCl, Tronothane (TN), Prestwick_1044, AC1L2KVS, Opera_ID_1593, AC1Q3DO8, MLS002222295, PRAXOMINE HYDROCHLORIDE, SCHEMBL180542, SPECTRUM1501139, CHEBI:8358, 140-65-8 (Parent), CHEMBL1201171, DTXSID2047777, KS-00000KOH, MolPort-003-666-364, HMS1570O13, HMS1921J07, Pharmakon1600-01501139, HY-B1319, NSC25573, Tox21_110477, KM0782, NSC-25573, NSC757847, s4092, AKOS015895041, Tox21_110477_1, AC-2094, API0003909, CCG-212937, CS-4643, MCULE-1100217744, NSC-757847, WLN: T6N DOTJ A3OR DO4 &GH, NCGC00016529-07, NCGC00094907-01, NCGC00094907-02, NCGC00094907-03, AN-14282, AS-12691, BC209186, LS-92487, AB0012331, FT-0603501, ST51015106, VU0239834-5, D00739, C-19995, I06-0440, Pramoxine hydrochloride, analytical standard, >=98%, SR-01000000243-3, 4-(3-(p-Butoxyphenoxy) propyl)-morpholine hydrochloride, 4-butoxy-1-(3-morpholin-4-ylpropoxy)benzene, chloride, 4-(3-(p-Butoxyphenoxy) propyl) -morpholine hydrochloride, p-Butoxyphenyl .gamma.-morpholinopropyl ether hydrochloride, .gamma.-Morpholinopropyl 4-N-butoxyphenyl ether hydrochloride, 4-[3-(4-Butoxyphenoxy)propyl]morpholine hydrochloride (1:1), Morpholine, 4-[3-(p-n-butoxyphenoxy )propyl]-, hydrochloride, Morpholine, 4-[3-(4-butoxyphenoxy)propyl]-, hydrochloride (1:1), Pramoxine hydrochloride, United States Pharmacopeia (USP) Reference Standard, Pramoxine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, AC1LAODB, 4-[3-(4-butoxyphenoxy)propyl]morpholin-4-ium chloride, AC1LCW6O, AKOS026749901, 4-[3-(4-butoxyphenoxy)propyl]morpholine; hydron; chloride